☆
4.5
Article
A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist anatibant (LF16-0687Ms) in patients with severe traumatic brain injury
JOURNAL OF NEUROTRAUMA (2005)
评价这篇论文
主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search